Please Wait
Applying Filters...
menu
    • menu
    Mix Gif-PSE
    News
    Shamrock Pharmachemi Acquires Full Control Of Unimark Remedies

    28 Nov 2024

    // PRESS RELEASE

    Bankruptcy court approves Intas-Shamrock plan for Unimark Remedies

    18 Apr 2023

    // ECONOMIC TIMES

    Shamrock Biopharma closes 304 M yuan in Series B financing

    28 Nov 2019

    // BIOSPECTRUM ASIA

    Data Compilation
    #PharmaFlow

    Read More

    Contact Supplier

    Website

    iPHEX India

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
    Menu

    Shamrock Pharmachemi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Unimark Remedies Limited

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    DIA 2025
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-03-04

    Unimark Remedies

    City : Pardi

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-03-04

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    APS Symposium
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-09-25

    Unimark Remedies

    City : Pardi

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-09-25

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Shamrock Pharmachemi and get a quotation

    Shamrock Pharmachemi is a supplier offers 10 products (APIs, Excipients or Intermediates).

    Find a price of Biapenem bulk offered by Shamrock Pharmachemi

    Find a price of Drotaverine bulk offered by Shamrock Pharmachemi

    Find a price of Ertapenem bulk offered by Shamrock Pharmachemi

    Find a price of Faropenem bulk offered by Shamrock Pharmachemi

    Find a price of Flecainide bulk offered by Shamrock Pharmachemi

    Find a price of Imipenem bulk offered by Shamrock Pharmachemi

    Find a price of Lisinopril bulk offered by Shamrock Pharmachemi

    Find a price of Montelukast Sodium bulk offered by Shamrock Pharmachemi

    Find a price of Nitrofurantoin bulk offered by Shamrock Pharmachemi

    Find a price of Tigecycline bulk offered by Shamrock Pharmachemi